Myeloid Gene Panel

This panel aids in the diagnosis, prognosis, and treatment planning of myeloid malignancies by providing a comprehensive genetic analysis. It identifies mutations that can guide targeted therapies and inform clinical decisions, leading to improved patient outcomes. By understanding the genetic underpinnings of myeloid disorders, this panel supports the development of personalized therapeutic strategies and enhances disease management.